Denali Therapeutics remains an intriguing clinical-stage biotech focused on neurodegenerative and lysosomal storage diseases.

DNL343 was Regimen G in the study, with the drug given to 186 patients who were compared to 139 in the placebo group, but was unable to show an improvement on the ALS Functional Rating Scale ...

A high-level overview of Denali Therapeutics Inc. (DNLI) stock. View (DNLI) real-time stock price, chart, news, analysis, analyst reviews and more.

SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the first quarter ended March 31, 2025, and provided business ...

Four more experimental drugs for amyotrophic lateral sclerosis (ALS) have failed to hit the primary endpoint in the phase 2/3 HEALEY ALS basket trial, which is trying to accelerate the search for ...

News Precautions urged when using fireworks The Fourth of July is almost here and with it comes fireworks. And while fireworks are fun for ... July 3, 2025 ...

The Triad Business Journal features local business news about Greensboro/Winston-Salem. We also provide tools to help businesses grow, network and hire.

The New York Times provides live news, investigations, opinion and video from the United States, Canada and around the world. Our 1,700 journalists report on politics from Washington and Ottawa ...

Watch CTV News Toronto at 11:30 for a comprehensive roundup of the top local stories across the GTHA.

The row between Elon Musk and Donald Trump escalates as the pair trade insults in a public feud after the SpaceX billionaire criticises the US president's signature tax bill.